{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:32:49Z","timestamp":1787891569333,"version":"build-2784847793"},"reference-count":102,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T00:00:00Z","timestamp":1407715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["APW200470477, APW201056718"],"award-info":[{"award-number":["APW200470477, APW201056718"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Risk Analysis"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:p>Managing the dynamics of vaccine supply and demand represents a significant challenge with very high stakes. Insufficient vaccine supplies can necessitate rationing, lead to preventable adverse health outcomes, delay the achievements of elimination or eradication goals, and\/or pose reputation risks for public health authorities and\/or manufacturers. This article explores the dynamics of global vaccine supply and demand to consider the opportunities to develop and maintain optimal global vaccine stockpiles for universal vaccines, characterized by large global demand (for which we use measles vaccines as an example), and nonuniversal (including new and niche) vaccines (for which we use oral cholera vaccine as an example). We contrast our approach with other vaccine stockpile optimization frameworks previously developed for the United States pediatric vaccine stockpile to address disruptions in supply and global emergency response vaccine stockpiles to provide on\u2010demand vaccines for use in outbreaks. For measles vaccine, we explore the complexity that arises due to different formulations and presentations of vaccines, consideration of rubella, and the context of regional elimination goals. We conclude that global health policy leaders and stakeholders should procure and maintain appropriate global vaccine rotating stocks for measles and rubella vaccine now to support current regional elimination goals, and should probably also do so for other vaccines to help prevent and control endemic or epidemic diseases. This work suggests the need to better model global vaccine supplies to improve efficiency in the vaccine supply chain, ensure adequate supplies to support elimination and eradication initiatives, and support progress toward the goals of the Global Vaccine Action Plan.<\/jats:p>","DOI":"10.1111\/risa.12265","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T14:02:49Z","timestamp":1407765769000},"page":"1487-1509","source":"Crossref","is-referenced-by-count":26,"title":["Framework for Optimal Global Vaccine Stockpile Design for Vaccine\u2010Preventable Diseases: Application to Measles and Cholera Vaccines as Contrasting Examples"],"prefix":"10.1111","volume":"36","author":[{"given":"Kimberly M.","family":"Thompson","sequence":"first","affiliation":[{"name":"Kid Risk, Inc  10524 Moss Park Rd., Ste. 204\u2010364 Orlando FL USA"},{"name":"University of Central Florida College of Medicine  Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radboud J.","family":"Duintjer Tebbens","sequence":"additional","affiliation":[{"name":"Kid Risk, Inc  10524 Moss Park Rd., Ste. 204\u2010364 Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,8,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00623-0"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-7185-2_1"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60532-7"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.026"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.08.072"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2011.0381"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2011.0382"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/499585"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1086\/499587"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omega.2010.12.004"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.6.6.981"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00196-1"},{"key":"e_1_2_8_14_1","unstructured":"GAVI Alliance.GAVI progress report 2011. Available at:http:\/\/gaviprogressreport.org\/2011\/ Accessed July 24 2012."},{"key":"e_1_2_8_15_1","volume-title":"Global Immunization Vision and Strategy 2006\u20132015","author":"WHO\u2010UNICEF","year":"2005"},{"key":"e_1_2_8_16_1","unstructured":"WHO\u2010UNICEF.WHO\u2010UNICEF Guidelines for Developing a Comprehensive Multi\u2010Year Plan. Report WHO\/IVB\/05.20. Geneva: World Health Organization 2005. Available at:http:\/\/www.who.int\/immunization\/documents\/WHO_IVB_05.20\/en\/ Accessed July 24 2012."},{"key":"e_1_2_8_17_1","unstructured":"Decade of Vaccines.Global Vaccines Action Plan. Available at:http:\/\/www.dovcollaboration.org\/action\u2010plan\/ Accessed July 24 2012."},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.07.045096"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.095"},{"key":"e_1_2_8_20_1","unstructured":"JarrettS.Vaccine shortages: Stephen Jarrett Deputy Director UNICEF Supply Division 2012. Available at:http:\/\/www.unicef.org\/immunization\/23244_shortage.html Accessed January 6 2014."},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2003.09.010"},{"key":"e_1_2_8_22_1","volume-title":"Annual Review of Public Health","author":"Hinman AR"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1086\/499591"},{"issue":"23","key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"2458, 2460, 246","DOI":"10.1093\/ajhp\/61.23.2458","article-title":"Vaccine shortages persist despite lessons from past","volume":"61","author":"Traynor K","year":"2004","journal-title":"American Journal of Health\u2010System Pharmacy"},{"issue":"30","key":"e_1_2_8_25_1","first-page":"667","article-title":"Impact of vaccine shortage on diphtheria and tetanus toxoids and acellular pertussis vaccine coverage rates among children aged 24 months\u2013Puerto Rico, 2002","volume":"51","author":"Rivera A","year":"2002","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2004.053306"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.075"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2004.053413"},{"key":"e_1_2_8_29_1","first-page":"1318","article-title":"Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib\u2010containing vaccines (PedvaxHIB and Comvax)","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_8_30_1","first-page":"673","article-title":"Updated recommendations for use of Haemophilus influenzae type b (Hib) vaccine: Reinstatement of the booster dose at ages 12\u201315 months","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_8_31_1","unstructured":"Centers for Disease Control and Prevention.Current vaccine shortages & delays 2014. Available at:http:\/\/www.cdc.gov\/vaccines\/vac\u2010gen\/shortages\/ Accessed May 10 2014."},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/15265160601021256"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-0090-5.00017-3"},{"key":"e_1_2_8_34_1","unstructured":"World Health Organization.Vaccine preventable diseases monitoring system \u2013 2013 global summary. Available at:http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/schedules Accessed May 16 2014."},{"key":"e_1_2_8_35_1","unstructured":"World Health Organization.WHO prequalified vaccines 2014. Available at:http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/PQ_vaccine_list_en\/en\/ Accessed May 16 2014."},{"key":"e_1_2_8_36_1","unstructured":"Immunization Action Coalition.Vaccine timeline: Historic dates and events related to vaccines and immunization. Available at:http:\/\/www.immunize.org\/timeline\/ Accessed May 17 2014."},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.04.001"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.18.2155"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10729-006-0001-5"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.02.004"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.3934\/jimo.2010.6.709"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2012.01891.x"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1540-2487(03)00044-0"},{"key":"e_1_2_8_44_1","unstructured":"World Health Organization.International Coordinating Group (ICG) on Vaccine Provision for Epidemic Meningitis control. Available at:http:\/\/www.who.int\/csr\/disease\/meningococcal\/icg\/en\/ Accessed May 11 2014."},{"key":"e_1_2_8_45_1","volume-title":"International Coordinating Group (ICG) on Vaccine Provision for Epidemic Meningitis Control. Report of the Seventh Meeting","author":"World Health Organization"},{"key":"e_1_2_8_46_1","unstructured":"World Health Organization.Yellow fever vaccine: A global partnership 2011. Available from:http:\/\/www.who.int\/csr\/disease\/yellowfev\/global_partnership\/en\/ Accessed May 11 2014."},{"key":"e_1_2_8_47_1","unstructured":"World Health Organization.Technical Working Group on Creation of an Oral Cholera Vaccine Stockpile 2012. Report No.: WHO\/HSE\/PED\/2012.2. Available at:http:\/\/www.who.int\/cholera\/publications\/oral_cholera_vaccine\/en\/index.html Accessed January 6 2014."},{"key":"e_1_2_8_48_1","unstructured":"World Health Organization.Oral cholera vaccine stockpile 2013. Available at:http:\/\/www.who.int\/cholera\/vaccines\/ocv_stockpile_2013\/en\/ Accessed January 6 2014."},{"key":"e_1_2_8_49_1","unstructured":"World Health Organization.Polio eradication and endgame strategic plan 2013\u20132018. Available at:http:\/\/www.polioeradication.org\/resourcelibrary\/strategyandwork.aspx Accessed January 6 2014."},{"issue":"8","key":"e_1_2_8_50_1","first-page":"190","article-title":"The case for cooperation in managing and maintaining the end of poliomyelitis: Stockpile needs and coordinated OPV cessation","volume":"10","author":"Thompson KM","year":"2008","journal-title":"Medscape Journal of Medicine"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.195"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00831.x"},{"key":"e_1_2_8_54_1","article-title":"WHO Guide for Standardization of Economic Evaluations of Immunization Programmes","author":"World Health Organization","year":"2008","journal-title":"Geneva: Initiative for Vaccine Research, Department of Immunization, Vaccine, and Biologicals"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7560.1000165"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12019"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.864563"},{"key":"e_1_2_8_58_1","unstructured":"World Health Organization.Global measles and rubella strategic plan 2012\u20132020. Available at:http:\/\/www.who.int\/immunization\/newsroom\/Measles_Rubella_StrategicPlan_2012_2020.pdf Accessed May 11 2014."},{"key":"e_1_2_8_59_1","unstructured":"World Health Organization.Maternal and neonatal tetanus elimination by 2005 2000. Available at:http:\/\/www.who.int\/vaccines\u2010documents\/DocsPDF02\/www692.pdf Accessed May 11 2014."},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1177\/003335491212700104"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/9780262016735.003.0009"},{"key":"e_1_2_8_62_1","volume-title":"Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health","author":"World Health Organization Commission on Macroeconomics and Health","year":"2001"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268806007096"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit845"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7560.1000183"},{"key":"e_1_2_8_66_1","doi-asserted-by":"crossref","unstructured":"FinePEM ClarksonJ A.Measles in England and Wales\u2014II:The impact of the Measles Vaccination Programme on the distribution of immunity in the population. International Journal of Epidemiology 1982;11:15\u201325.","DOI":"10.1093\/ije\/11.1.15"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.11.091"},{"issue":"12","key":"e_1_2_8_68_1","first-page":"1","article-title":"Update: Vaccine side effects, adverse reaction, contraindications, and precautions \u2014 Recommendation of the Advisory Committee on Immunization Practices (ACIP)","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir117"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir075"},{"key":"e_1_2_8_71_1","article-title":"Systematic review of health economic analyses of measles and rubella immunization interventions","author":"Thompson KM","year":"2014","journal-title":"Risk Analysis"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir111"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir130"},{"key":"e_1_2_8_74_1","unstructured":"Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat.World population prospects: The 2012 revision 2013. Available at:http:\/\/esa.un.org\/unpd\/wpp\/index.htm Accessed September 11 2013."},{"issue":"35","key":"e_1_2_8_75_1","first-page":"349","article-title":"Measles vaccine: WHO position paper","volume":"84","author":"World Health Organization","year":"2009","journal-title":"Weekly Epidemiological Record"},{"issue":"10","key":"e_1_2_8_76_1","first-page":"726","article-title":"Single\u2010dose versus multi\u2010dose vaccine vials for immunization programmes in developing countries","volume":"81","author":"Drain PK","year":"2003","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.05.048"},{"key":"e_1_2_8_78_1","unstructured":"World Health Organization.Policy statement. The use of opened multi\u2010dose vials of vaccine in subsequent immunization sessions. Geneva Switzerland: WHO: WHO\/V&B\/00.09 2000."},{"issue":"1","key":"e_1_2_8_79_1","first-page":"12","article-title":"Meeting of the strategic advisory group of experts on immunization, November 2013 \u2014 Conclusions and recommendations","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Weekly Epidemiological Record"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir072"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00843.x"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2007.1038"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.110"},{"key":"e_1_2_8_84_1","volume-title":"Response to Measles Outbreaks in Measles Mortality Reduction Settings","author":"World Health Organization","year":"2009"},{"issue":"3","key":"e_1_2_8_85_1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/oxfordjournals.aje.a114676","article-title":"A cost\u2010effectiveness analysis of measles outbreak control strategies","volume":"126","author":"Davis RM","year":"1987","journal-title":"American Journal of Epidemiology"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.1998.tb01156.x"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060775"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2512"},{"key":"e_1_2_8_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir115"},{"issue":"12","key":"e_1_2_8_90_1","first-page":"374","article-title":"Measles outbreaks and progress toward measles preelimination\u2014African region, 2009\u20132010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_8_91_1","unstructured":"GAVI Alliance.GAVI boosts global response to measles outbreaks 2012. Available at:http:\/\/www.gavialliance.org\/library\/news\/press\u2010releases\/2012\/gavi\u2010boosts\u2010global\u2010response\u2010to\u2010measles\u2010outbreaks\/ Accessed January 6 2014."},{"key":"e_1_2_8_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/sdr.419"},{"key":"e_1_2_8_93_1","doi-asserted-by":"publisher","DOI":"10.2307\/41166101"},{"key":"e_1_2_8_94_1","doi-asserted-by":"publisher","DOI":"10.2307\/41166100"},{"key":"e_1_2_8_95_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1105807108"},{"key":"e_1_2_8_96_1","volume-title":"Use of the Two\u2010Dose Oral Cholera Vaccine in the Context of a Major Natural Disaster","author":"World Health Organization","year":"2006"},{"key":"e_1_2_8_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66550-6"},{"key":"e_1_2_8_98_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1102149108"},{"key":"e_1_2_8_99_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040336"},{"key":"e_1_2_8_100_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000952"},{"key":"e_1_2_8_101_1","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/9780262016735.003.0010"},{"issue":"4","key":"e_1_2_8_102_1","first-page":"9","article-title":"Valuing prevention as the new paradigm in global health: Managing population immunity for vaccine\u2010preventable diseases","volume":"12","author":"Thompson KM","year":"2012","journal-title":"ICU Management"},{"key":"e_1_2_8_103_1","unstructured":"Centers for Disease Control and Prevention.Serogroup b meningococcal vaccine and outbreaks. Available at:http:\/\/www.cdc.gov\/meningococcal\/outbreaks\/vaccine\u2010serogroupB.html Accessed May 17 2014"}],"container-title":["Risk Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Frisa.12265","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/risa.12265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:45:18Z","timestamp":1694619918000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/risa.12265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,11]]},"references-count":102,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1111\/risa.12265"],"URL":"https:\/\/doi.org\/10.1111\/risa.12265","archive":["Portico"],"relation":{},"ISSN":["0272-4332","1539-6924"],"issn-type":[{"value":"0272-4332","type":"print"},{"value":"1539-6924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,11]]}}}